A growing number of people who have Type 1 diabetes, which requires daily insulin shots, are going without that vital medicine, or making potentially fatal self-reductions in their doses, due to the skyrocketing cost of insulin. Costs have nearly doubled over five years.
In this podcast Mike Patrick discusses this healthcare crisis with Ray Kimmelblatt, Executive Director of JDRF (formerly the Juvenile Diabetes Research Foundation) and looks at options for reducing those costs.
Photo: Getty Images